KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Inventory (2016 - 2025)

Historic Inventory for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to $39.1 million.

  • NovoCure's Inventory rose 2.05% to $39.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.1 million, marking a year-over-year increase of 2.05%. This contributed to the annual value of $35.1 million for FY2024, which is 803.63% down from last year.
  • Per NovoCure's latest filing, its Inventory stood at $39.1 million for Q3 2025, which was up 2.05% from $40.2 million recorded in Q2 2025.
  • NovoCure's Inventory's 5-year high stood at $42.4 million during Q1 2024, with a 5-year trough of $22.6 million in Q3 2021.
  • Over the past 5 years, NovoCure's median Inventory value was $33.0 million (recorded in 2023), while the average stood at $33.3 million.
  • In the last 5 years, NovoCure's Inventory plummeted by 1449.07% in 2021 and then surged by 3737.68% in 2023.
  • Over the past 5 years, NovoCure's Inventory (Quarter) stood at $24.4 million in 2021, then grew by 20.26% to $29.4 million in 2022, then rose by 29.87% to $38.2 million in 2023, then fell by 8.04% to $35.1 million in 2024, then increased by 11.45% to $39.1 million in 2025.
  • Its Inventory was $39.1 million in Q3 2025, compared to $40.2 million in Q2 2025 and $39.5 million in Q1 2025.